|
EP1239876B1
(en)
|
1999-11-19 |
2008-07-30 |
Csl Limited |
Hcv vaccine compositions
|
|
EP2000144A1
(en)
|
2000-05-19 |
2008-12-10 |
Corixa Corporation |
Prophylactic and therapeutic treatment of infectious, autoimmune and allergic diseases with mono-and disaccharide-based compounds
|
|
EP1382352A1
(de)
|
2002-07-19 |
2004-01-21 |
GBF Gesellschaft für Biotechnologische Forschung mbH |
Bisacyloxypropylcystein-Konjugate und deren Verwendung
|
|
BR0313101A
(pt)
|
2002-08-12 |
2005-06-28 |
Queensland Inst Med Res |
Novos lipopeptìdeos imunogênicos que compreendem epitopos de linfócitos t-helper e linfócitos t citotóxicos (ctl), e métodos para sua produção e uso
|
|
EP2301972A1
(en)
|
2002-08-12 |
2011-03-30 |
The Council Of The Queensland Institute Of Medical Research |
Method to prepare immunogenic lipopeptides comprising T-helper and B-cell epitopes
|
|
EP1550458A1
(en)
|
2003-12-23 |
2005-07-06 |
Vectron Therapeutics AG |
Synergistic liposomal adjuvants
|
|
US20060002941A1
(en)
|
2004-01-23 |
2006-01-05 |
Vievax Corp. |
Compositions comprising immune response altering agents and methods of use
|
|
WO2005079419A2
(en)
|
2004-02-17 |
2005-09-01 |
The Regents Of The University Of California |
Methods of treating immunopathological disorders
|
|
GB0405634D0
(en)
|
2004-03-12 |
2004-04-21 |
Univ Southampton |
Anti-virus therapy for respiratory diseases
|
|
GB0411411D0
(en)
|
2004-05-21 |
2004-06-23 |
Glaxosmithkline Biolog Sa |
Vaccines
|
|
CN102614510A
(zh)
|
2004-10-18 |
2012-08-01 |
全球免疫股份有限公司 |
基于酵母的对慢性丙型肝炎感染的治疗
|
|
EP1666056A1
(en)
|
2004-12-06 |
2006-06-07 |
Bestewil Holding B.V. |
Cancer vaccine vesicles
|
|
NZ556004A
(en)
|
2004-12-21 |
2010-05-28 |
Vaxinnate Corp |
Compositions of influenza viral proteins comprising at least one flagellin and at least one influenza M2 protein
|
|
BRPI0607605A2
(pt)
|
2005-02-08 |
2009-09-15 |
Queensland Inst Med Res |
moléculas imunogênicas
|
|
AU2006216822A1
(en)
|
2005-02-22 |
2006-08-31 |
Daniel Rachmilewitz |
Methods of treating gastrointestinal inflammation
|
|
EP1787660A1
(en)
*
|
2005-11-22 |
2007-05-23 |
GBF Gesellschaft für Biotechnologische Forschung mbH |
New adjuvants on the basis of bisacyloxypropylcysteine conjugates and their uses in pharmaceutical compositions
|
|
US20070224205A1
(en)
|
2006-03-07 |
2007-09-27 |
Powell Thomas J |
Compositions that include hemagglutinin, methods of making and methods of use thereof
|
|
WO2008085549A2
(en)
|
2006-07-28 |
2008-07-17 |
Board Of Regents Of The University Of Texas System |
Compositions and methods for stimulation of lung innate immunity
|
|
AU2014202674B2
(en)
*
|
2007-05-04 |
2014-08-14 |
Marina Biotech, Inc. |
Amino acid lipids and uses thereof
|
|
EP2200638B1
(en)
|
2007-10-09 |
2016-03-16 |
The University of Melbourne |
Compositions for the transfection of cells
|
|
WO2009137103A2
(en)
|
2008-05-09 |
2009-11-12 |
Ourth Donald D |
Anti-cancer/anti-viral compounds and methods of use
|
|
WO2009155332A1
(en)
|
2008-06-17 |
2009-12-23 |
Cedars-Sinai Medical Center |
Use of toll-like receptor ligands as adjuvants to vaccination therapy for brain tumors
|
|
EP2334332A4
(en)
|
2008-09-05 |
2013-01-09 |
Id Biomedical Corp Quebec |
NEW COMPOSITIONS AND NEW ADJUVANTS
|
|
KR20110117705A
(ko)
|
2009-02-11 |
2011-10-27 |
더 리전트 오브 더 유니버시티 오브 캘리포니아 |
톨-유사 수용체 조정제 및 질병의 치료
|
|
ES2534947T3
(es)
|
2009-03-25 |
2015-04-30 |
The Board Of Regents Of The University Of Texas System |
Composiciones para la estimulación de resistencia inmunitaria innata de mamíferos a patógenos
|
|
WO2010115229A1
(en)
|
2009-04-09 |
2010-10-14 |
The University Of Melbourne |
Immunogenic composition and uses thereof
|
|
GB0907989D0
(en)
|
2009-05-08 |
2009-06-24 |
Hybrid Systems Ltd |
Multivalent adjuvant display
|
|
EP2338521A1
(en)
|
2009-12-28 |
2011-06-29 |
Helmholtz-Zentrum für Infektionsforschung GmbH |
Lipopeptide- and lipoprotein-conjugates and its use
|
|
AU2011232421B2
(en)
*
|
2010-03-23 |
2015-08-13 |
Novartis Ag |
Compounds (cystein based lipopeptides) and compositions as TLR2 agonists used for treating infections, inflammations, respiratory diseases etc.
|
|
DK2618842T3
(da)
|
2010-09-22 |
2019-07-01 |
Ena Therapeutics Pty Ltd |
Hidtil ukendt immunstimulerende fremgangsmåde
|
|
JP6240077B2
(ja)
*
|
2011-10-06 |
2017-11-29 |
イムノバクシーン・テクノロジーズ・インコーポレイテッドＩｍｍｕｎｏｖａｃｃｉｎｅ Ｔｅｃｈｎｏｌｏｇｉｅｓ Ｉｎｃ． |
Ｔｌｒ２を活性化するか、またはその活性を増加させるアジュバントを含むリポソーム組成物およびその使用
|
|
WO2014207708A2
(en)
|
2013-06-28 |
2014-12-31 |
Auckland Uniservices Limited |
Amino acid and peptide conjugates and conjugation process
|
|
WO2016037240A1
(en)
|
2014-09-12 |
2016-03-17 |
The University Of Melbourne |
Immunological reagent
|
|
US10286065B2
(en)
|
2014-09-19 |
2019-05-14 |
Board Of Regents, The University Of Texas System |
Compositions and methods for treating viral infections through stimulated innate immunity in combination with antiviral compounds
|
|
JP2016216593A
(ja)
|
2015-05-19 |
2016-12-22 |
株式会社リコー |
反応材、熱交換器及びケミカルヒートポンプ
|
|
US20180222982A1
(en)
|
2015-07-29 |
2018-08-09 |
Novartis Ag |
Combination therapies comprising antibody molecules to pd-1
|
|
EP3419962A4
(en)
|
2016-02-26 |
2020-03-11 |
Auckland Uniservices Limited |
CONJUGATES OF AMINO ACIDS AND PEPTIDES AND CONJUGATION METHOD
|
|
US20200147028A1
(en)
|
2017-03-31 |
2020-05-14 |
Ena Therapeutics Pty Ltd |
Treatment of respiratory infection with a tlr2 agonist
|
|
NL2018803B1
(en)
*
|
2017-04-27 |
2018-11-05 |
Academisch Ziekenhuis Leiden Handelend Onder De Naam Leids Univ Medisch Centrum/ H O D N Lumc |
Adjuvant compounds
|
|
KR20200058424A
(ko)
*
|
2017-08-30 |
2020-05-27 |
오클랜드 유니서비시즈 리미티드 |
펩티드 접합체, 접합 방법, 및 그의 용도
|
|
US20210177795A1
(en)
|
2017-12-21 |
2021-06-17 |
Ena Therapeutics Pty Ltd |
Administering compounds
|
|
EP3728289B1
(en)
*
|
2017-12-21 |
2025-09-10 |
Axelia Oncology Pty Ltd |
Optimised compounds
|
|
KR20220050873A
(ko)
*
|
2019-06-26 |
2022-04-25 |
악셀리아 온콜로지 피티와이 리미티드 |
신규한 분자
|
|
US20220347146A1
(en)
|
2019-09-04 |
2022-11-03 |
Axelia Oncology Pty Ltd |
Cancer treatment
|
|
WO2021042171A1
(en)
|
2019-09-04 |
2021-03-11 |
Ena Therapeutics Pty Ltd |
Cancer immunotherapy
|
|
EP4157255A4
(en)
|
2020-05-26 |
2024-07-03 |
Ena Respiratory Pty Ltd |
CORONAVIRUS TREATMENT
|